DISCOVERY OF NOVEL KINASE INHIBITORS FOR THE TREATMENT OF HEPATOCELLULAR CARCINOMA

被引：0

作者：

Toffanin, S. ^{[1
,2
]}

Cabellos, L. ^{[1
]}

Dong, H. ^{[1
]}

Alsinet, C. ^{[3
]}

Harrington, A. ^{[1
]}

Cornella, H. ^{[3
]}

Reddy, R. V. ^{[4
]}

Reddy, P. M. ^{[4
]}

Llovet, J. M. ^{[1
,3
,5
]}

机构：

[1] Mt Sinai Sch Med, Div Liver Dis, Liver Canc Program, New York, NY USA

[2] Fdn IRCCS, Ist Nazl Tumori, Dept Surg & Expt Oncol, Hepatooncol Grp, Milan, Italy

[3] Univ Barcelona, Ctr Invest Biomed Red Enfermedades Hepat & Digest, HCC Translat Res Lab,Hosp Clin,IDIBAPS, Barcelona Clin Liver Canc Grp BCLC,Liver Unit, Barcelona, Spain

[4] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY USA

[5] Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain

来源：

JOURNAL OF HEPATOLOGY | 2013年 / 58卷

关键词：

D O I：

10.1016/S0168-8278(13)61093-4

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

1092

引用

页码：S446 / S447

页数：2

共 50 条

[21] Discovery of novel inhibitors for the treatment of glaucoma
Cholkar, Kishore
Trinh, Hoang M.
Pal, Dhananjay
Mitra, Ashim K.
EXPERT OPINION ON DRUG DISCOVERY, 2015, 10 (03) : 293 - 313
[22] Moving targets in hepatocellular carcinoma: Hepatic progenitor cells as novel targets for tyrosine kinase inhibitors
Siegel, Abby
GASTROENTEROLOGY, 2008, 135 (03) : 733 - 735
[23] Discovery of Novel α-Carboline Inhibitors of the Anaplastic Lymphoma Kinase
Mologni, Luca
Tardy, Sebastien
Zambon, Alfonso
Orsato, Alexandre
Bisson, William H.
Ceccon, Monica
Viltadi, Michela
D'Attoma, Joseph
Pannilunghi, Sara
Vece, Vito
Bertho, Jerome
Goekjian, Peter
Scapozza, Leonardo
Gambacorti-Passerini, Carlo
ACS OMEGA, 2022, 7 (20): : 17083 - 17097
[24] Discovery of wrightiadione as a novel template for the TrkA kinase inhibitors
Jeong, Yujeong
Lim, Sang Min
Hong, Sungwoo
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (22) : 5186 - 5189
[25] Discovery of novel selective spleen tyrosine kinase inhibitors
Northrup, Alan B.
Altman, Michael D.
Andresen, Brian M.
Anthony, Neville J.
Arrington, Kenneth L.
Bhat, Sathesh
Bienstock, Corey E.
Black, Cameron
Burch, Jason
Butcher, John W.
Childers, Kaleen Konrad
Cote, Bernard
Deschenes, Denis
di Francesco, Emilia
Donofrio, Anthony
Ducharme, Yves
Dupont-Gaudet, Kristina
Ellis, J. Michael
Fischer, Christian
Fournier, Jean-Francois
Friesen, Rick
Gauthier, Jacques Yves
Grimm, Jonathan B.
Guay, Daniel
Guerin, David J.
Haidle, Andrew M.
Jewell, James P.
Kattar, Solomon D.
Li, Chaomin
Lim, Jongwon
Lee, Sandra
Liu, Yuan
Machacek, Michelle R.
Maddess, Matthew L.
Miller, Thomas A.
O'Boyle, Brendan M.
Otte, Ryan D.
Peterson, Scott L.
Petrocchi, Alessia
Reutershan, Michael H.
Romeo, Eric T.
Robichaud, Joel S.
Schell, Adam J.
Siu, Tony
Smith, Graham F.
Spencer, Kerrie B.
Taoka, Brandon M.
Trotter, B. Wesley
Yang, Liping
Woo, Hyun Chong
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 247
[26] Virtual Screening and Discovery of Novel Aurora Kinase Inhibitors
Raghu, R.
Devaraji, Vinod
Leena, K.
Riyaz, Sd.
Rani, Polavaru Baby
Kumar, Suneel B.
Naik, Pradeep Kumar
Dubey, P. K.
Velmurugan, Devadasan
Vijayalakshmi, M.
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2014, 14 (17) : 2006 - 2019
[27] Histone deacetylase inhibitors for treatment of hepatocellular carcinoma
Coradini, D
Speranza, A
ACTA PHARMACOLOGICA SINICA, 2005, 26 (09) : 1025 - 1033
[28] Discovery of Novel 7-Azaindole Derivatives as Selective Covalent Fibroblast Growth Factor Receptor 4 Inhibitors for the Treatment of Hepatocellular Carcinoma
Zhong, Zhenpeng
Shi, Liyang
Fu, Tiancheng
Huang, Jiajun
Pan, Zhengying
JOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (10) : 7278 - 7295
[29] Histone deacetylase inhibitors for treatment of hepatocellular carcinoma
Danila CORADINI
Annalisa SPERANZA
ActaPharmacologicaSinica, 2005, (09) : 1025 - 1033
[30] Immune checkpoint inhibitors in the treatment of hepatocellular carcinoma
Akbulut, Zeynep
Aru, Basak
Aydin, Furkan
Demirel, Gulderen Yanikkaya
FRONTIERS IN IMMUNOLOGY, 2024, 15

← 1 2 3 4 5 →